AHCL17.78

Anlon Healthcare Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersANUHPHRWANBURYBAJAJHCAREZIMLABTHEMISMEDLINCOLNSIGACHIVALIANTLABMcap ₹94.5 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations50.987.6
Other Income0.00.1
Total Income50.987.6
Expenses
+ Cost of Materials Consumed52.873.0
+ Changes in Inventories-24.9-7.0
+ Employee Benefit Expense1.51.9
+ Finance Costs0.60.9
+ Depreciation & Amortisation0.31.1
+ Other Expenses6.23.9
Total Expenses36.574.0
EBITDA15.315.6
EBIT15.014.5
Profit
PBT before Exceptional Items14.413.7
Pretax Income14.413.7
+ Current Tax1.93.5
+ Deferred Tax1.51.9
Tax Expense3.45.4
Net Income11.18.3
+ Net Income — Continuing Ops11.18.3
+ Other Comprehensive Income-0.1-0.0
Total Comprehensive Income11.08.3
Net Income to Common10.50.0
Minority Interest0.60.0
Per Share
Basic EPS2.330.16
Diluted EPS2.330.16
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.1-0.0
+ Items NOT to be Reclassified to P&L-0.0
+ Tax on Items NOT to be Reclassified0.1-0.0
+ Tax on Items to be Reclassified-0.00.0
Comprehensive Income — Owners of Parent10.40.0
Comprehensive Income — Non-controlling Interests0.60.0
Per Share — as-filed variants
Basic EPS — Continuing Operations2.330.16
Diluted EPS — Continuing Operations2.330.16
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit23.021.5
Gross Margin %45.2824.53
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)14.413.7
Net Income Adj (tax-effected)11.18.3
EPS Adj2.330.16
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.002.00
Paid Up Equity Capital53.2106.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.